StockData
ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31

INTUITIVE SURGICAL INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$433.18+6.48 (+1.52%)

Close on Oct 19, 2026

Market cap
$154.78B
P/E (TTM)
49.6
Dividend yield
–

Earnings

Next report expected Oct 20, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 16, 2026After market close$2.89B$2.29$2.80
Q1 FY2026
Ended Mar 31, 2026
Apr 21, 2026After market close$2.77B$2.28$2.50
Q4 FY2025
Ended Dec 31, 2025
Jan 14, 2026Before market open$2.87B––
Q3 FY2025
Ended Sep 30, 2025
Oct 21, 2025After market close$2.51B$1.95$2.40
Q2 FY2025
Ended Jun 30, 2025
Jul 22, 2025After market close$2.44B$1.81$2.19
Q1 FY2025
Ended Mar 31, 2025
Apr 22, 2025After market close$2.25B$1.92$1.81
Q4 FY2024
Ended Dec 31, 2024
Jan 15, 2025Before market open$2.41B––
Q3 FY2024
Ended Sep 30, 2024
Oct 17, 2024After market close$2.04B$1.56$1.84
Q2 FY2024
Ended Jun 30, 2024
Jul 18, 2024After market close$2.01B$1.46$1.78
Q1 FY2024
Ended Mar 31, 2024
Apr 18, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Jan 9, 2024After market close–––

Company guidance

Outlook given with results on Jul 16, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
Non-GAAP* gross profit marginnon-GAAPthe full year of 202668% to 69%Raised
Worldwide da Vinci procedure growththe full year of 202613.5% to 15.5% growthMaintained
Non-GAAP* operating expense growthnon-GAAPthe full year of 202611% to 13% growthLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Intuitive Surgical filed with the SEC